Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
Physical activity provides clinical benefit in Parkinson’s disease (PD). Irisin is an exercise-induced polypeptide secreted by skeletal muscle that crosses the blood–brain barrier and mediates certain effects of exercise. Here, we show that irisin prevents pathologic α-synuclein (α-syn)-induced neurodegeneration in the α-syn preformed fibril (PFF) mouse model of sporadic PD. Intravenous delivery of irisin via viral vectors following the stereotaxic intrastriatal injection of α-syn PFF cause a reduction in the formation of pathologic α-syn and prevented the loss of dopamine neurons and lowering of striatal dopamine. Irisin also substantially reduced the α-syn PFF-induced motor deficits as assessed behaviorally by the pole and grip strength test. Recombinant sustained irisin treatment of primary cortical neurons attenuated α-syn PFF toxicity by reducing the formation of phosphorylated serine 129 of α-syn and neuronal cell death. Tandem mass spectrometry and biochemical analysis revealed that irisin reduced pathologic α-syn by enhancing endolysosomal degradation of pathologic α-syn. Our findings highlight the potential for therapeutic disease modification of irisin in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Additionally, irisin reduces the formation of pathologic α-syn, prevents the loss of dopaminergic neurons, and improves α-syn-induced motor deficits.383”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [383]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Perseus computational platform for comprehensive analysis of (prote)omics data
Tyanova, S., Temu, T., Sinitcyn, P., Carlson, A., Hein, M. Y., Geiger, T., Mann, M., & Cox, J. (2016) · Nature Methods · doi:10.1038/nmeth.3901 · Cited by 8,803
Parkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810
Self-citationElias, J. E., & Gygi, S. P. (2007) · Nature Methods · doi:10.1038/nmeth1019 · Cited by 3,925
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Single-pot, solid-phase-enhanced sample preparation for proteomics experiments
Hughes, C. S., Moggridge, S., Müller, T., Sorensen, P. H., Morin, G. B., & Krijgsveld, J. (2019) · Nature Protocols · doi:10.1038/s41596-018-0082-x · Cited by 1,941
A tissue-specific atlas of mouse protein phosphorylation and expression
Huttlin, E. L., Jedrychowski, M. P., Elias, J. E., Goswami, T., Rad, R., Beausoleil, S. A., Villén, J., Haas, W., Sowa, M. E., & Gygi, S. P. (2010) · Cell · doi:10.1016/j.cell.2010.12.001 · Cited by 1,778
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway
Wrann, C. D., White, J. P., Salogiannnis, J., Laznik-Bogoslavski, D., Wu, J., Ma, D., Lin, J. D., Greenberg, M. E., & Spiegelman, B. M. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.008 · Cited by 1,440
Self-citationUltrasensitive proteome analysis using paramagnetic bead technology
Hughes, C. S., Foehr, S., Garfield, D. A., Furlong, E. E., Steinmetz, L. M., & Krijgsveld, J. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145625 · Cited by 1,225
Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models
Lourenco, M. V., Frozza, R. L., de Freitas, G. B., Zhang, H., Kincheski, G. C., Ribeiro, F. C., Gonçalves, R. A., Clarke, J. R., Beckman, D., Staniszewski, A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0275-4 · Cited by 935
Pathophysiology of bradykinesia in Parkinson's disease
Berardelli, A. (2001) · Brain · doi:10.1093/brain/124.11.2131 · Cited by 906
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
Holmes, B. B., DeVos, S. L., Kfoury, N., Li, M., Jacks, R., Yanamandra, K., Ouidja, M. O., Brodsky, F. M., Marasa, J., Bagchi, D. P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301440110 · Cited by 859
Choi, S. H., Bylykbashi, E., Chatila, Z. K., Lee, S. W., Pulli, B., Clemenson, G. D., Kim, E., Rompala, A., Oram, M. K., Asselin, C., et al. (2018) · Science · doi:10.1126/science.aan8821 · Cited by 802
Self-citationPathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
Mao, X., Ou, M. T., Karuppagounder, S. S., Kam, T.-I., Yin, X., Xiong, Y., Ge, P., Umanah, G. E., Brahmachari, S., Shin, J.-H., et al. (2016) · Science · doi:10.1126/science.aah3374 · Cited by 690
Self-citationDistinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
Guo, J. L., Covell, D. J., Daniels, J. P., Iba, M., Stieber, A., Zhang, B., Riddle, D. M., Kwong, L. K., Xu, Y., Trojanowski, J. Q., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.057 · Cited by 680
Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors
Kim, H., Wrann, C. D., Jedrychowski, M., Vidoni, S., Kitase, Y., Nagano, K., Zhou, C., Chou, J., Parkman, V.-J. A., Novick, S. J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.025 · Cited by 638
Self-citationDetection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry
Jedrychowski, M. P., Wrann, C. D., Paulo, J. A., Gerber, K. K., Szpyt, J., Robinson, M. M., Nair, K. S., Gygi, S. P., & Spiegelman, B. M. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.001 · Cited by 558
Self-citationα-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesis
Mehra, S., Sahay, S., & Maji, S. K. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.03.001 · Cited by 499
Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease
Kam, T.-I., Mao, X., Park, H., Chou, S.-C., Karuppagounder, S. S., Umanah, G. E., Yun, S. P., Brahmachari, S., Panicker, N., Chen, R., et al. (2018) · Science · doi:10.1126/science.aat8407 · Cited by 476
Self-citationA Scalable Approach for Protein False Discovery Rate Estimation in Large Proteomic Data Sets
Savitski, M. M., Wilhelm, M., Hahne, H., Kuster, B., & Bantscheff, M. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.046995 · Cited by 445
Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes
Abounit, S., Bousset, L., Loria, F., Zhu, S., de Chaumont, F., Pieri, L., Olivo‐Marin, J., Melki, R., & Zurzolo, C. (2016) · The EMBO Journal · doi:10.15252/embj.201593411 · Cited by 414
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
Giguère, N., Burke Nanni, S., & Trudeau, L.-E. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00455 · Cited by 413
Exercise hormone irisin is a critical regulator of cognitive function
Islam, M. R., Valaris, S., Young, M. F., Haley, E. B., Luo, R., Bond, S. F., Mazuera, S., Kitchen, R. R., Caldarone, B. J., Bettio, L. E. B., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00438-z · Cited by 403
Self-citationSchweppe, D. K., Eng, J. K., Yu, Q., Bailey, D., Rad, R., Navarrete-Perea, J., Huttlin, E. L., Erickson, B. K., Paulo, J. A., & Gygi, S. P. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00860 · Cited by 286
Karuppagounder, S. S., Brahmachari, S., Lee, Y., Dawson, V. L., Dawson, T. M., & Ko, H. S. (2014) · Scientific Reports · doi:10.1038/srep04874 · Cited by 264
Self-citationBras, J., Guerreiro, R., Darwent, L., Parkkinen, L., Ansorge, O., Escott-Price, V., Hernandez, D. G., Nalls, M. A., Clark, L. N., Honig, L. S., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu334 · Cited by 230
Brown, B. M., Peiffer, J. J., & Martins, R. N. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.162 · Cited by 228
APOE,MAPT, and SNCA Genes and Cognitive Performance in Parkinson Disease
Mata, I. F., Leverenz, J. B., Weintraub, D., Trojanowski, J. Q., Hurtig, H. I., Van Deerlin, V. M., Ritz, B., Rausch, R., Rhodes, S. L., Factor, S. A., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1455 · Cited by 205
Is Physical Exercise Beneficial for Persons with Parkinson's Disease?
Crizzle, A. M., & Newhouse, I. J. (2006) · Clinical Journal of Sport Medicine · doi:10.1097/01.jsm.0000244612.55550.7d · Cited by 195
APOE genotype regulates pathology and disease progression in synucleinopathy
Davis, A. A., Inman, C. E., Wargel, Z. M., Dube, U., Freeberg, B. M., Galluppi, A., Haines, J. N., Dhavale, D. D., Miller, R., Choudhury, F. A., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay3069 · Cited by 177
Karpowicz, R. J., Haney, C. M., Mihaila, T. S., Sandler, R. M., Petersson, E. J., & Lee, V. M.-Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.780296 · Cited by 172
Cell-to-Cell Transmission of Tau and α-Synuclein
Uemura, N., Uemura, M. T., Luk, K. C., Lee, V. M.-Y., & Trojanowski, J. Q. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.03.012 · Cited by 149
Shu, H.-F., Yang, T., Yu, S.-X., Huang, H.-D., Jiang, L.-L., Gu, J.-W., & Kuang, Y.-Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100503 · Cited by 145
Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology
Asahina, M., Vichayanrat, E., Low, D. A., Iodice, V., & Mathias, C. J. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303135 · Cited by 140
Role of physical activity in Parkinson's disease
Tan, L. S., Bhalsing, K. S., & Abbas, M. M. (2018) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_169_18 · Cited by 137
Physical Exercise For Parkinson’s Disease: Clinical And Experimental Evidence
de Carvalho, A. O., Filho, A. S. S., Murillo‐Rodríguez, E., Rocha, N., Carta, M. G., & Machado, S. E. D. C. (2018) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/1745017901814010089 · Cited by 136
Improved Monoisotopic Mass Estimation for Deeper Proteome Coverage
Rad, R., Li, J., Mintseris, J., O’Connell, J., Gygi, S. P., & Schweppe, D. K. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00563 · Cited by 121
Membrane binding, internalization, and sorting of alpha-synuclein in the cell
Masaracchia, C., Hnida, M., Gerhardt, E., Lopes da Fonseca, T., Villar-Pique, A., Branco, T., Stahlberg, M. A., Dean, C., Fernández, C. O., Milosevic, I., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0578-1 · Cited by 93
Li, Q., Jia, S., Xu, L., Li, B., & Chen, N. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.1006 · Cited by 79
Irisin reverses insulin resistance in C2C12 cells via the p38-MAPK-PGC-1α pathway
Ye, X., Shen, Y., Ni, C., Ye, J., Xin, Y., Zhang, W., & Ren, Y. (2019) · Peptides · doi:10.1016/j.peptides.2019.170120 · Cited by 72
Irisin Improves Autophagy of Aged Hepatocytes via Increasing Telomerase Activity in Liver Injury
Bi, J., Yang, L., Wang, T., Zhang, J., Li, T., Ren, Y., Wang, M., Chen, X., Lv, Y., & Wu, R. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6946037 · Cited by 69
Klejman, A., Węgrzynowicz, M., Szatmari, E. M., Mioduszewska, B., Hetman, M., & Albrecht, J. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.04.006 · Cited by 66
Irisin ameliorates angiotensin II‐induced cardiomyocyte apoptosis through autophagy
Li, R., Wang, X., Wu, S., Wu, Y., Chen, H., Xin, J., Li, H., Lan, J., Xue, K., Li, X., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28382 · Cited by 64
Preventive and Therapeutic Potential of Physical Exercise in Neurodegenerative Diseases
Marques-Aleixo, I., Beleza, J., Sampaio, A., Stevanović, J., Coxito, P., Gonçalves, I., Ascensão, A., & Magalhães, J. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8075 · Cited by 61
Kam, T.-I., Park, H., Gwon, Y., Song, S., Kim, S.-H., Moon, S. W., Jo, D.-G., & Jung, Y.-K. (2016) · eLife · doi:10.7554/elife.18691 · Cited by 49
Self-citationIrisin protects the substantia nigra dopaminergic neurons in the rat model of Parkinson's disease.
Zarbakhsh, S., Safari, M., Aldaghi, M. R., Sameni, H. R., Ghahari, L., Lagmouj, Y. K., Jaberi, K. R., & Parsaie, H. (2019) · PubMed · doi:10.22038/ijbms.2019.33444.7987 · Cited by 41
Direct Observation of α-Synuclein Amyloid Aggregates in Endocytic Vesicles of Neuroblastoma Cells
Apetri, M. M., Harkes, R., Subramaniam, V., Canters, G. W., Schmidt, T., & Aartsma, T. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153020 · Cited by 38
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Self-citationα-Synuclein pathology as a target in neurodegenerative diseases
Park, H.-J., Kam, T., Dawson, V. L., & Dawson, T. M. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01043-w · Cited by 125
Self-citationLv, Q.-K., Tao, K., Yao, X., Pang, M., Cao, B., Liu, C., & Wang, F. (2024) · Journal of Pineal Research · doi:10.1111/jpi.12948 · Cited by 113
Molecular insights of exercise therapy in disease prevention and treatment
Walzik, D., Chirino, T. Y. W., Zimmer, P., & Joisten, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01841-0 · Cited by 105
Irisin acts through its integrin receptor in a two-step process involving extracellular Hsp90α
Mu, A., Wales, T. E., Zhou, H., Draga-Coletă, S.-V., Gorgulla, C., Blackmore, K. A., Mittenbühler, M. J., Kim, C. R., Laznik-Bogoslavski, D., Zhang, Q., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.05.008 · Cited by 92
Self-citation
Metadata
- Authors
- Kam, T.-I., Park, H., Chou, S.-C., Van Vranken, J. G., Mittenbühler, M. J., Kim, H., A, M., Choi, Y. R., Biswas, D., Wang, J., Shin, Y., Loder, A., Karuppagounder, S. S., Wrann, C. D., Dawson, V. L., Spiegelman, B. M., & Dawson, T. M.
- Affiliations
- Johns Hopkins University (US)
- Department of Cell Biology, Harvard Medical School, Boston, MA, 02215
- Harvard University (US)
- Corresponding author
- Spiegelman, Bruce M.
- Dawson, Ted M.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2022-08-31
- Volume
- 119
- Issue
- 36
- Pages
- e2204835119-e2204835119
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC9457183
- OpenAlex
- W4293785272
- Cited by
- 125
- References
- 51
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 39 · 2023: 20 · 2022: 3
- FWCI
- 13.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- JPB Foundation (N/A)
- Maryland Stem Cell Research Fund (2020-MSCRFL-5427)
- Damon Runyon Cancer Research Foundation (DRG 2359-19)
- Deutsche Forschungsgemeinschaft (461079553)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- irisin, Parkinson's disease, alpha-synuclein, preformed fibrils, neurodegeneration, dopaminergic neurons, striatum, motor impairment, serine 129 phosphorylation, endolysosomal degradation, viral gene delivery, physical activity
- MeSH terms
- Animals, Corpus Striatum, Disease Models, Animal, Fibronectins, Parkinson Disease, Mice, alpha-Synuclein, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.